Product
LCI699
1 clinical trial
1 indication
Indication
Cushing's diseaseClinical trial
A Phase II, Multicenter, Open-label, Non-comparative Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Osilodrostat in Children and Adolescent Patients With Cushing's DiseaseStatus: Recruiting, Estimated PCD: 2025-11-21